144 ·Filed Aug 4, 2026

CI

Cigna Group
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001959173-26-005596
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Routine Form 144 notice — no material trading signal. Monitor for any cluster of insider selling or sudden increase in sale volume, but this single filing is standard for an officer's diversification or tax planning.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
CI ▲ +3.52% at T+20d
NEUTRAL call ✓ call won +3.52% · α vs SPY +4.75% · entry $273.45 → $283.06
Next anchor: T+60d in 26d
Latest observation: T+40 +0.86% FF3 residual α
Entry anchored
Aug 4, 01:48 PM ET
via exchange tick
T+1d
-1.40%
call -1.40% · α -1.20%
$269.61
settled 8w ago
T+5d
+0.16%
call +0.16% · α +0.25%
$273.87
settled 7w ago
T+20d
+3.52%
call +3.52% · α +4.75%
$283.06
settled 4w ago
T+60d
—
call — · α —
—
in 26d

Price Chart

Loading chart...

Executive Summary

Nicole S. Jones, an Officer of Cigna Group, filed a Form 144 notice of intent to sell 19,436 shares of common stock with an estimated market value of $5.37 million. The shares were acquired through restricted stock vesting and a stock option exercise. This is a routine insider sale of modest size relative to Cigna's $73.8B market cap and carries no material negative signal.

Key Facts

  • Insider: Nicole S. Jones, Officer of The Cigna Group
  • Proposed sale of 19,436 shares of common stock
  • Estimated market value of $5,369,583.72
  • Shares sourced from restricted stock vesting (2015-2026) and a stock option cash exercise on 08/04/2026 for 14,045 shares
  • Sale to be executed through Fidelity Brokerage Services LLC on NYSE
  • Filing date: 2026-08-04

Financial Impact

Sale of ~$5.4M represents approximately 0.007% of Cigna's $73.8B market cap — immaterial

dilutioninsider holdings

Risk Factors

  • No material downside risk from this filing alone
  • Future insider selling patterns could shift sentiment if large or aggressive

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
85% bullish (33 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-005596
Document: 0001959173-26-005596-index.html0001959173-26-005596
Document: 0001959173-26-005596.txt0001959173-26-005596
10 reports for CI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CI — sortable, filterable
TypeNow
Sep 3, 2026
28d ago
144
NEUTRAL ★ 2/10
$286.26 $280.76▼ −1.92%▼ −0.77%$267.96 (−6.39%)
Aug 18, 2026
6w ago
144
NEUTRAL ★ 2/10
$278.50 $279.32▲ +0.29%▲ +0.50%$267.96 (−3.78%)
Aug 4, 2026
8w ago
144
NEUTRAL ★ 2/10
$273.45 $273.87▲ +0.16%▲ +0.25%$267.96 (−2.01%)
Jul 9, 2026
12w ago
3
NEUTRAL ★ 2/10
$293.46 $283.82▼ −3.28%▼ −2.72%$267.96 (−8.69%)
May 13, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$300.42 $291.28▼ −3.04%▼ −1.88%$267.96 (−10.80%)
May 6, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$281.98 $300.71▲ +6.64%▲ +5.49%$267.96 (−4.97%)
Apr 30, 2026
22w ago
8-K
BULLISH ★ 7/10
$290.33 $283.65▼ −2.30%▼ −4.03%$267.96 (−7.70%)
Apr 24, 2026
23w ago
Court Ruling
NEUTRAL ★ 3/10
$275.24 $290.58▲ +5.57%▲ +4.67%$267.96 (−2.64%)
Mar 13, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$268.31 $261.49▼ −2.54%▼ −0.50%$267.96 (−0.13%)
Feb 27, 2026
31w ago
8-K
NEUTRAL ★ 4/10
$289.40 $271.04▼ −6.34%▼ −4.36%$267.96 (−7.41%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access